Comparison between clopidogrel and ticagrelor in CYP2C19 loss-of-function alleles coronary artery disease and stroke patients: a meta-analysis.
- DOI
- 10.1007/s00228-025-03860-4
- Published
- 2025 Sep
- Container
- European journal of clinical pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00228-025-03860-4,
title = {Comparison between clopidogrel and ticagrelor in CYP2C19 loss-of-function alleles coronary artery disease and stroke patients: a meta-analysis.},
author = {Elsayed M and Moawad MHED and Elkholy M and Ahmed Y and Nabgouri Y and Bahtiyarova G and Alkhawaldeh IM and Abouzid M and Wagih RM},
year = {2025},
journal = {European journal of clinical pharmacology},
doi = {10.1007/s00228-025-03860-4},
url = {https://doi.org/10.1007/s00228-025-03860-4}
}RIS
TY - JOUR TI - Comparison between clopidogrel and ticagrelor in CYP2C19 loss-of-function alleles coronary artery disease and stroke patients: a meta-analysis. AU - Elsayed M AU - Moawad MHED AU - Elkholy M AU - Ahmed Y AU - Nabgouri Y AU - Bahtiyarova G AU - Alkhawaldeh IM AU - Abouzid M AU - Wagih RM PY - 2025 JO - European journal of clinical pharmacology DO - 10.1007/s00228-025-03860-4 UR - https://doi.org/10.1007/s00228-025-03860-4 ER -
APA
M, E., MHED, M., M, E., Y, A., Y, N., G, B., IM, A., M, A., & RM, W. (2025). Comparison between clopidogrel and ticagrelor in CYP2C19 loss-of-function alleles coronary artery disease and stroke patients: a meta-analysis.. European journal of clinical pharmacology. https://doi.org/10.1007/s00228-025-03860-4
Source records
- pubmed · retrieved 2026-11-10T15:54:52.990Z